News from xtl biopharmaceuticals ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 12, 2014, 08:00 ET

XTL Biopharmaceuticals Receives Correspondence Regarding Nasdaq Listing Requirements

 XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

Jun 02, 2014, 09:00 ET

XTL Biopharmaceuticals Reports Financial and Operational Results for the First Quarter of 2014

XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

May 19, 2014, 08:00 ET

XTL Biopharmaceuticals Further Strengthens Team for Phase II Lupus Trial with Two Additional Experts

 XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

Apr 02, 2014, 16:41 ET

XTL Biopharmaceuticals Reports Financial and Operational Results for the Full Year Ended 2013

 XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

Mar 25, 2014, 08:00 ET

XTL Biopharmaceuticals Retains Expert Consultants in Rheumatology for Phase II Lupus Trial

XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

Jan 08, 2014, 08:00 ET

XTL Biopharmaceuticals In-licenses hCDR1, a Phase 2 Clinical Stage Asset for the Treatment of Lupus

XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) (TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the...

Jul 15, 2013, 13:30 ET

XTL Biopharmaceuticals' ADRs Commence Trading on NASDAQ Stock Market

XTL Biopharmaceuticals, Ltd. (NASDAQ: XTLB) (TASE: XTL) (the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition,...

Jul 10, 2013, 13:45 ET

XTL Biopharmaceuticals Returns to NASDAQ

XTL Biopharmaceuticals Ltd. (the "Company") (TASE: XTL), (OTC: XTLBY) announced today that NASDAQ approved the Company's listing application and...

Dec 05, 2012, 11:20 ET

Following the Acquisition of the Controlling Stake by XTL, Proteologics Appoints Board Members and Chairman

XTL Biopharmaceuticals Ltd (TASE: XTL) (OTC: XTLBY) (the "Company", or "XTL"), a biopharmaceutical development company that recently acquired the...

Nov 26, 2012, 16:21 ET

XTL Biopharmaceuticals Acquires Stake in Proteologics Ltd.

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced on November...

Oct 04, 2012, 14:51 ET

XTL Biopharmaceuticals Effectuates ADR Ratio Change

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that following the...

Oct 04, 2012, 12:18 ET

XTL Biopharmaceuticals Effectuates ADR Ratio Change

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that following the...

Sep 24, 2012, 17:00 ET

Strategic Online Marketing Agreement signed by InterCure, XTL Biopharmaceuticals' Subsidiary

XTL Biopharmaceuticals Ltd. ("XTL") today announced that InterCure Ltd. ("InterCure"), which is approximately 45.4% (50.79% on a fully diluted...

Sep 24, 2012, 12:57 ET

XTL Biopharmaceuticals Provides Favorable Update on NASDAQ Listing Process

 XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that it...

Jun 19, 2012, 10:14 ET

XTL Biopharmaceuticals to Acquire Kitov Pharmaceuticals

XTL Biopharmaceuticals Ltd. (TASE:XTL)(OTC:XTLBY), a biopharmaceutical development company, announced today it will acquire Kitov...

Jun 11, 2012, 14:59 ET

XTL Biopharmaceuticals Joins Two Additional Indexes on TASE

XTL Biopharmaceuticals Ltd. (TASE:XTL,OTC:XTLBY), a biopharmaceutical development company, announces it has been notified by the Tel Aviv Stock...

Jun 04, 2012, 12:22 ET

XTL Biopharmaceuticals Files Application for Listing on the NASDAQ

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that it has filed...

Apr 17, 2012, 10:32 ET

XTL Biopharmaceuticals Ltd. Names Dr. Ben-Zion Weiner to its Board of Directors

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced yesterday that Dr....

Apr 16, 2012, 16:16 ET

XTL Biopharmaceuticals Ltd. Signs Letter of Intent to Acquire a Drug Development Company

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (hereinafter, "XTL"), a biopharmaceutical development company, announced yesterday that on...

Mar 29, 2012, 18:55 ET

XTL Biopharmaceuticals Reports Full-Year 2011 Results

XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY), a biopharmaceutical development company, today reported its results for the fourth quarter...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge